IMMUNE-MEDIATED ARTHRITIS

This adverse event was reported 381 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED ARTHRITIS:

# Drug Count
0 NIVOLUMAB 135
1 IPILIMUMAB 75
2 CARBOPLATIN 62
3 PACLITAXEL 26
4 PEMETREXED DISODIUM 26
5 PEMETREXED 24
6 CISPLATIN 14
7 DURVALUMAB 14
8 ESOMEPRAZOLE 9
9 ESOMEPRAZOLE MAGNESIUM 9
See all common drugs associated with IMMUNE-MEDIATED ARTHRITIS

IMMUNE-MEDIATED ARTHRITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZONGERTINIB 1 0.0060
1 NIVOLUMAB AND RELATLIMAB-RMBW 1 0.0019
2 XYLOMETAZOLINE HYDROCHLORIDE 1 0.0018
3 IPILIMUMAB 75 0.0017
4 NIVOLUMAB 135 0.0014
5 TREMELIMUMAB 5 0.0011
6 FOSNETUPITANT AND PALONOSETRON 1 0.0008
7 NETUPITANT AND PALONOSETRON 1 0.0008
8 WHITE PETROLATUM 1 0.0007
9 POTASSIUM IODIDE 1 0.0007
See all drugs enriched for association with IMMUNE-MEDIATED ARTHRITIS